(Q34349869)

1 August 2017

1 reference

title

Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation (English)

1 reference

1 August 2017

0 references

Barber MD

1

1 reference

1 August 2017

publication date

1 September 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

17

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

751-755

1 reference

1 August 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Adjuvant therapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Changes in nutritional status associated with unresectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Proceedings: Causes of death in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Energy expenditure in malnourished cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Metabolic response to enteral food in different phases of cancer cachexia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Protein synthesis in muscle measured in vivo in cachectic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Liver export proteins and trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

The relationship between weight loss and interleukin 6 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Acute-phase protein response and survival duration of patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

1 reference

7 January 2021

Tumour necrosis factor in man: clinical and biological observations

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Tumor necrosis factor and the acute metabolic response to tissue injury in man

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Interleukin-1-induced anorexia in the rat. Influence of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Effects of human recombinant interleukin-1β on protein synthesis in rat tissues compared with a classical acute-phase reaction induced by turpentine. Rapid response of muscle to interleukin-1β

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Tumor Necrosis Factor Not Detectable in Patients With Clinical Cancer Cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Combined hormonal infusion simulates the metabolic response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Both inflammatory and endocrine mediators stimulate host responses to sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Tumor host relations. I. Increased plasma cortisol in tumor-bearing humans compared with patients with benign surgical diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Peripheral Tissue Metabolism in Cancer-bearing Man

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Mechanism of depletion of liver glycogen in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Parenteral nutrition in patients receiving cancer chemotherapy. American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Megestrol acetate in cancer anorexia and weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Body-composition changes in patients who gain weight while receiving megestrol acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Effect of extended ibuprofen administration on the acute phase protein response in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Effect of ibuprofen on the acute-phase response and protein metabolism in patients with cancer and weight loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Cardiovascular Effects of n-3 Fatty Acids

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Dietary fish oil suppresses human colon tumour growth in athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Fish oil and plasma fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900631-1

7 January 2021

10.1016/S0899-9007(01)00631-1

Identifiers

DOI

1 reference

1 August 2017

1 reference